previously number of years, the UK has witnessed a revolution in clinical excess weight‑reduction remedies — within the introduction of semaglutide (Wegovy®) for the growing attractiveness of tirzepatide (Mounjaro®). Now, One more name is drawing awareness in each clinical and general public well